glp 1 death Frontiers GLP-1 drugs reduce risk of
Description
Key Features
GLP-1 agonists work by regulating appetite hormones and blood sugar, addressing both menopause-specific weight gain and metabolic slowdown
Explore how this medical weight management option could support your goals.
INTRODUCTION:While ubiquity of glucagon-like peptide receptor agonists (GLP1-RAs) is rising, guidance from the gastroenterology societies and...
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) drug use appears to be associated with increased residual gastric content (RGC) detected by gastric ultrasonography, a major risk factor for aspiration
June 6, 2025 A large retrospective review of more than 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events and inpatient admissions
